# Modified antioxIdants Bacteria for Gut Inflammation

> **NCT06189599** · — · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 500 (estimated)

## Conditions studied

- Chronic Inflammatory Small Bowel Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06189599
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02-01
- **Primary completion:** 2024-02-02
- **Final completion:** 2024-06-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2024-01-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06189599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06189599, "Modified antioxIdants Bacteria for Gut Inflammation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06189599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*